These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9829154)

  • 1. Current recommendations for the prophylaxis and treatment of rabies.
    Dreesen DW; Hanlon CA
    Drugs; 1998 Nov; 56(5):801-9. PubMed ID: 9829154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
    MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
    Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett SM; Levis R; Meltzer MI; Schaffner W; Cieslak PR;
    MMWR Recomm Rep; 2010 Mar; 59(RR-2):1-9. PubMed ID: 20300058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revised 4-dose vaccine schedule as part of postexposure prophylaxis to prevent human rabies.
    Mittal MK
    Pediatr Emerg Care; 2013 Oct; 29(10):1119-21;quiz 1122-4. PubMed ID: 24084614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [WHO recommended pre-exposure prophylaxis for rabies using Japanese rabies vaccine].
    Yanagisawa N; Takayama N; Suganuma A
    Kansenshogaku Zasshi; 2008 Sep; 82(5):441-4. PubMed ID: 18975587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
    Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview, prevention, and treatment of rabies.
    Nigg AJ; Walker PL
    Pharmacotherapy; 2009 Oct; 29(10):1182-95. PubMed ID: 19792992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in human rabies prophylaxis.
    Warrell MJ
    Rev Sci Tech; 2018 Aug; 37(2):629-647. PubMed ID: 30747121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.
    Warrell MJ
    Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Revision of the rabies policy in the Netherlands].
    de Pijper CA; Schreuder I; Vollaard AM; Visser LG; van Kessel R; van den Kerkhof JHTC; Stijnis C
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabies postexposure consultations in New Zealand from 1998 to 2012.
    Shaw MT; Visser J; Edwards C
    J Travel Med; 2015; 22(1):31-8. PubMed ID: 25315202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals.
    Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett S; Levis R; Meltzer MI; Schaffner W; Cieslak PR
    Vaccine; 2009 Nov; 27(51):7141-8. PubMed ID: 19925944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives on rabies postexposure prophylaxis.
    Blaise A; Gautret P
    Infect Disord Drug Targets; 2015; 15(1):13-9. PubMed ID: 25809623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
    Alberer M; Gnad-Vogt U; Hong HS; Mehr KT; Backert L; Finak G; Gottardo R; Bica MA; Garofano A; Koch SD; Fotin-Mleczek M; Hoerr I; Clemens R; von Sonnenburg F
    Lancet; 2017 Sep; 390(10101):1511-1520. PubMed ID: 28754494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans.
    Mansfield KL; Andrews N; Goharriz H; Goddard T; McElhinney LM; Brown KE; Fooks AR
    Vaccine; 2016 Nov; 34(48):5959-5967. PubMed ID: 27997343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-immunization and post-exposure treatment with inactivated rabies vaccine of chick embryo cell culture origin (CEC).
    Kondo A
    Dev Biol Stand; 1978; 40():147-53. PubMed ID: 98373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.